HIND Vyome Therapeutics: Forvard narx/daromad multiplikatori

Vyome Holdings Inc (HIND) - korporativ logo

Vyome Holdings Inc (HIND) kompaniyasining forward P/S koeffitsiyenti savdo baholash tendentsiyasini aks ettiradi va hozirda ushbu ko'rsatkich 72.70 darajasida turibdi. Vyome Holdings Inc (HIND) jamoasi R&D kengayishi orqali immunologiya va vazn yo'qotish bo'yicha ekspertlarni ishga olmoqda. Daromad Lap-Band tizimlari va yangi farmatsevtika vositalarining joriy etilishi hisobiga shakllanmoqda, biroq aktivlarni qayta tuzilishi sababli moliyaviy barqarorlik qat'iy nazoratni talab qiladi.

HIND (Vyome Holdings) Bozor kapitallashuvining kelajakdagi daromadga nisbati tarixi 16.08.2025dan 18.11.2026gacha

Vyome Holdings Inc (HIND) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning dastlabki tahlili:ReShape Lifesciences (HIND)
Vyome Therapeutics original mahsuloti

Vyome Holdings Inc (HIND) uchun DART platformasining chidamli infeksiyalarni davolashdagi salohiyati kelgusidagi daromad oqimlarining bozor qiymatini belgilaydi, bu esa forward P/S ga asoslangan baholashni o'ta muhim qiladi. Forward P/S dinamikasini tahlil qilish orqali investor joriy bozor kapitalizatsiyasining prognoz qilingan savdolarga nisbatini ko'rishi mumkin, bu esa aktivlarning haddan tashqari qimmat baholanganini aniqlash yoki kutilayotgan daromadlar past baholanganda kirish nuqtasini topish imkonini beradi.

Muhim raqobatchilar

Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|Narxning prognoz qilingan daromadga nisbati Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati CLDX (Celldex Therapeutics)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharma AUPH|Sotuvga nisbatan forvard narx BCRX|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PGEN (Intrexon)|Forvard narx/daromad multiplikatori PHAR (Pharming)|NKTR (Nektar) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Kelajakdagi narxning daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Gossamer Bio Inc GOSS|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna Pharma|PVLA (Pieris Corp) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati SVRA|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori AnaptysBio Corp ANAB|Astria Therapeutics Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|KYTX: Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori VTYX (Ventyx Biosciences)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati theratech.com|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc.)|Forvard P/S multiplikatori Eledon Pharmaceuticals Inc. ELDN|AGEN: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx CLYM (Climb Bio, Inc)|ZURA: Forvard P/S multiplikatori|aTyr Pharma, Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Adagene Inc.|IMA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori STTK|Forvard narx/daromad multiplikatori Equillium Bio EQ|Narxning prognoz qilingan daromadga nisbati Connect Biopharma CNTB|IMUX - Forvard narx/daromad multiplikatori|ATRA - Narxning prognoz qilingan daromadga nisbati|InflaRx NV (IFRX) - Forvard narx/daromad multiplikatori|XFOR (X4 Pharmaceuticals Inc.) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Adicet Bio Inc. (ACET)|Narxning prognoz qilingan daromadga nisbati celularity.com|Forvard narx/daromad multiplikatori inmunebio.com (INMB)|Narxning prognoz qilingan daromadga nisbati Barinthus Biotherapeutics PLC (BRNS)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Akari Therapeutics, Plc (AKTX)|ENLV: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Edesa|Narxning prognoz qilingan daromadga nisbati iBio, Inc.|Forvard narx/daromad multiplikatori carismatx.com (CARM)|Forvard P/S multiplikatori XTLB|Forvard narx/daromad multiplikatori Bolt Bio BOLT|Forvard P/S multiplikatori HCWB (HCW Biologics)|APVO: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AIM - Narxning prognoz qilingan daromadga nisbati|ADTX - Forvard P/S multiplikatori|GRI Bio (GRI) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori XORTX Therapeutics|Narxning prognoz qilingan daromadga nisbati Revelation Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Indaptus Therapeutics, Inc. INDP|Narxning prognoz qilingan daromadga nisbati BiondVax Pharmaceuticals (SCNI)|Forvard narx/daromad multiplikatori CalciMedica CALI|Narxning prognoz qilingan daromadga nisbati Affimed AFMD|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA Pharma, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com